Project Details
Description
Phase II Study of Dasatinib in Previously Treated Patients with Advanced (stage IV) Non-Small Cell Lung Cancer (NSCLC)
| Status | Finished |
|---|---|
| Effective start/end date | 1/13/10 → 1/31/15 |
Funding
- DUKE UNIVERSITY
- BRISTOL-MYERS SQUIBB PHARM RES
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.